1. Home
  2. QNRX vs AMS Comparison

QNRX vs AMS Comparison

Compare QNRX & AMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quoin Pharmaceuticals Ltd.

QNRX

Quoin Pharmaceuticals Ltd.

HOLD

Current Price

$8.69

Market Cap

14.5M

Sector

Health Care

ML Signal

HOLD

Logo American Shared Hospital Services

AMS

American Shared Hospital Services

HOLD

Current Price

$2.11

Market Cap

13.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QNRX
AMS
Founded
2018
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.5M
13.9M
IPO Year
2023
1995

Fundamental Metrics

Financial Performance
Metric
QNRX
AMS
Price
$8.69
$2.11
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
24.4K
8.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
230.00
EPS
N/A
N/A
Revenue
N/A
$19,714,000.00
Revenue This Year
N/A
$3.81
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.81
52 Week Low
$0.21
$2.02
52 Week High
$41.80
$3.11

Technical Indicators

Market Signals
Indicator
QNRX
AMS
Relative Strength Index (RSI) 47.01 44.16
Support Level $8.03 $2.04
Resistance Level $10.05 $2.19
Average True Range (ATR) 0.80 0.08
MACD 0.20 -0.01
Stochastic Oscillator 47.73 8.06

Price Performance

Historical Comparison
QNRX
AMS

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

About AMS American Shared Hospital Services

American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.

Share on Social Networks: